Back to results
US 2006/0235065 A1Published application
Aminopyrazole derivatives
AssigneeHoffmann-La Roche Inc.
InventorsGuy Georges, Bernhard Goller, Klaus-Peter Kuenkele, Aude Lemarchand, Anja Limberg, Ulrike Reiff, Petra Rueger, Matthias Rueth
Life of this patent
Estimating the term…
Abstract
The present invention relates to the compounds of formula I: their pharmaceutically acceptable salts or esters, enantiomeric forms, diastereoisomers and racemates, the preparation of the above-mentioned compounds, pharmaceutical compositions containing them and their manufacture, as well as the use of such compounds in the control or prevention of illnesses such as cancer.
Claims40
A compound according to formula I and all pharmaceutically acceptable salts or esters thereof wherein formula I is:
- wherein:
- (a) R1 is selected from the group consisting of:
- (1) hydrogen;
- (2) alkyl, which is optionally substituted one or more times with nitro, cyano or —Y—R6;
- (3) alkenyl, which is optionally substituted one or more times with nitro, cyano or —Y—R6;
- and
- (4) alkynyl, which is optionally substituted one or more times with nitro, cyano or —Y—R6;
- (b) Y is selected from the group consisting of:
- (1) a single bond;
- (2) —C(O)NH—;
- (3) —C(O)N(alkyl)-;
- (4) —N(alkyl)C(O)—;
- (5) —NHC(O)—;
- (6) —NHC(O)NH—;
- (7) —NHC(O)N(alkyl)-;
- (8) —NHS(O)2—;
- (9) —S(O)2NH—;
- (10) —S(O)2N(alkyl)-;
- (11) —S(O)2—;
- (12) —S(O)—;
- (13) —C(O)O—;
- (14) —OC(O)—;
- (15) —C(O)—;
- (16) —P(O)(alkyl)-;
- (17) —NH—;
- (18) —N(alkyl)-;
- (19) —O—;
- and
- (20) —S—;
- (c) R6 is selected from the group consisting of:
- (1) alkyl, which is optionally substituted one or more times by halogen, hydroxy, alkoxy, alkoxyalkoxy, amino, alkylamino, dialkylamino, —C(O)OH or —C(O)NH2;
- (2) aryl, which is optionally substituted one or more times by halogen, cyano, nitro, amino, hydroxy, (C1-C4)alkyl, (C1-C4)alkoxy, halogenated (C1-C4)alkyl or halogenated (C1-C4)alkoxy;
- (3) heteroaryl, which is optionally substituted one or more times by alkyl;
- (4) cycloalkyl;
- and
- (5) heterocyclyl;
- (d) R2 and R3 form together with the carbon atom to which they are attached a (C5-C6)cycloalkyl ring, or alternatively, R2 and R3 are independently selected from the group consisting of:
- (1) hydrogen;
- and
- (2) alkyl;
- (e) Z is selected from the group consisting of:
- (1) —C(O)—,
- (2) —C(O)NR7,
- (3) —C(O)O—,
- (4) —S(O)2—, and
- (5) —S(O)2NR7—;
- (f) n is 0 or 1;
- (g) R7 is hydrogen or alkyl;
- (h) R4 is selected from the group consisting of:
- (1) hydrogen;
- (2) alkyl, which is optionally substituted one or more times by halogen, hydroxy, alkoxy, alkoxyalkoxy, amino, alkylamino or dialkylamino;
- (3) aryl-V—, wherein the aryl is optionally substituted one or more times by halogen, cyano, nitro, amino, alkylamino, dialkylamino, 2,4-dioxa-pentan-1,5-diyl, 2,5-dioxa-hexan-1,6-diyl, hydroxy, (C1-C4)alkyl, (C1-C4)alkoxy, halogenated (C1-C4)alkyl or halogenated (C1-C4)alkoxy;
- (4) heteroaryl-V—, wherein the heteroaryl is optionally substituted one or more times by alkyl;
- (5) cycloalkyl-V—;
- and
- (6) heterocyclyl-V—;
- with the proviso that R4 is not hydrogen, if n is 1 and Z is —C(O)O—;
- (i) V is selected from the group consisting of:
- (1) a single bond,
- (2) alkylene,
- (3) —O-alkylene,
- (4) cycloalkylene, and
- (5) alkenylene;
- (j) R5 is selected from the group consisting of:
- (1) hydrogen,
- (2) alkyl,
- (3) fluorine, and
- (4) chlorine;
- and
- (k) X is a single bond, —CH2— or —C(alkyl)2—.
67 more elements
Dependencies are inferred from the claim text.